Relation between presynaptic and postsynaptic dopaminergic functions measured by positron emission tomography: Implication of dopaminergic tone

Journal of Neuroscience

Volumn 31, Issue 21, 2011, Pages 7886-7890

  Ito, Hiroshi ^a   Kodaka, Fumitoshi ^a   Takahashi, Hidehiko ^a   Takano, Harumasa ^a   Arakawa, Ryosuke ^a   Shimada, Hitoshi ^a   Suhara, Tetsuya ^a  

^a NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON 11; DOPAMINE; DOPAMINE 2 RECEPTOR; RACLOPRIDE;

ADULT; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORPUS STRIATUM; CORRELATION ANALYSIS; DOPAMINE METABOLISM; DOPAMINERGIC SYSTEM; GENE CONTROL; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PERSONALITY; POSITRON EMISSION TOMOGRAPHY; POSTSYNAPTIC POTENTIAL; PRESYNAPTIC POTENTIAL; PRIORITY JOURNAL; RECEPTOR BINDING;

ADULT; DOPAMINE; HUMANS; MALE; POSITRON-EMISSION TOMOGRAPHY; PRESYNAPTIC TERMINALS; PROTEIN BINDING; RACLOPRIDE; RECEPTORS, DOPAMINE D2; SYNAPTIC POTENTIALS; YOUNG ADULT;

EID: 79957649282     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.6024-10.2011     Document Type: Article

References (43)

1. 2 receptor density and personal detachment in healthy subjects. Am J Psychiatry 155:1440-1442.
2. Brix G, Zaers J, Adam LE, Bellemann ME, Ostertag H, Trojan H, Haberkorn U, Doll J, Oberdorfer F, Lorenz WJ (1997) Performance evaluation of a whole-body PET scanner using the NEMA protocol. J Nucl Med 38:1614-1623.
3. Brown RM, Crane AM, Goldman PS (1979) Regional distribution of monoamines in the cerebral cortex and subcortical structures of the rhesus monkey: concentrations and in vivo synthesis rates. Brain Res 168: 133-150.
4. Farde L, Ehrin E, Eriksson L, Greitz T, Hall H, Hedström CG, Litton JE, Sedvall G (1985) Substituted benzamides as ligands for visualization of dopamine receptor binding in the human brain by positron emission tomography. Proc Natl Acad Sci U S A 82:3863-3867.
5. 11Craclopride. Psychopharmacology 92:278-284.
6. 11C]raclopride. Arch Gen Psychiatry 47:213-219.
7. 11C]raclopride in man. Synapse 20:200-208.
8. 2 dopamine receptors and personality traits. Nature 385:590.
9. Friston KJ, Frith CD, Liddle PF, Dolan RJ, Lammertsma AA, Frackowiak RS (1990) The relationship between global and local changes in PET scans. J Cereb Blood Flow Metab 10:458-466.
10. Gjedde A (1988) Exchange diffusion of large neutral amino acids between blood and brain. In: Peptide and amino acid transport mechanisms in the cerebral nervous system (Rakic L, Begley DJ, Davson H, Zlokovic BV, eds), pp 209-217. New York: Stockton.
11. Gjedde A, Reith J, Dyve S, Léger G, Guttman M, Diksic M, Evans A, Kuwabara H (1991) Dopa decarboxylase activity of the living human brain. Proc Natl Acad Sci U S A 88:2721-2725.
12. Grace AA (1991) Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience 41:1-24.
13. 11C-labelled SCH 23390 for the in vivo study of dopamine D-1 receptors using positron emission tomography. Int J Rad Appl Instrum A 37:1039-1043.
14. 11C]dopa in humans studied by positron emission tomography. J Neural Transm Gen Sect 86:25- 41.
15. 18F]DMFP PET study in detoxified alcoholic patients. Am J Psychiatry 162:1515-1520.
16. Hietala J, Syvälahti E, Vuorio K, Räkköläinen V, Bergman J, Haaparanta M, Solin O, Kuoppamäki M, Kirvelä O, Ruotsalainen U, Salokangas RKR (1995) Presynaptic dopamine function in striatum of neuroleptic-naïve schizophrenic patients. Lancet 346:1130 -1131.
17. 18F]fluoro-dopa in human positron emission tomographic studies. J Cereb Blood Flow Metab 11:898-913.
18. Innis RB, Cunningham VJ, Delforge J, Fujita M, Gjedde A, Gunn RN, Holden J, Houle S, Huang SC, Ichise M, Iida H, Ito H, Kimura Y, Koeppe RA, Knudsen GM, Knuuti J, Lammertsma AA, Laruelle M, Logan J, Maguire RP, et al. (2007) Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab 27:1533-1539.
19. 18F]-fluorophenylalanine and PET. J Nucl Med 36:1232-1237.
20. 11C]raclopride binding. J Cereb Blood Flow Metab 18:941-950.
21. 11C]DOPA. Nucl Med Commun 27:723-731.
22. 11C]DOPA. Ann Nucl Med 21:355-360.
23. Ito H, Takahashi H, Arakawa R, Takano H, Suhara T (2008) Normal data-base of dopaminergic neurotransmission system in human brain measured by positron emission tomography. Neuroimage 39:555-565.
24. Jönsson E, Sedvall G, Brené S, Gustavsson JP, Geijer T, Terenius L, Crocq MA, Lannfelt L, Tylec A, Sokoloff P, Schwartz JC, Wiesel FA (1996) Dopamine-related genes and their relationships to monoamine metabolites in CSF. Biol Psychiatry 40:1032-1043.
25. 2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers. Mol Psychiatry 4:290-296.
26. 2 receptor availability in ventral striatum correlates with central processing of affective stimuli. Eur J Nucl Med Mol Imaging 35:1147-1158.
27. 3H-raclopride.Apotent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain. Biochem Pharmacol 34:2251-2259.
28. Laakso A, Wallius E, Kajander J, Bergman J, Eskola O, Solin O, Ilonen T, Salokangas RK, Syvälahti E, Hietala J (2003) Personality traits and striatal dopamine synthesis capacity in healthy subjects. Am J Psychiatry 160:904-910.
29. 2 dopamine receptor gene is associated with increased activity of striatal L-amino acid decarboxylase in healthy subjects. Pharmacogenet Genomics 15:387-391.
30. Lammertsma AA, Hume SP (1996) Simplified reference tissue model for PET receptor studies. Neuroimage 4:153-158.
31. 11C]raclopride studies. J Cereb Blood Flow Metab 16:42-52.
32. 11C) DOPA and PET. Biol Psychiatry 46:681- 688.
33. Lloyd KG, Hornykiewicz O (1972) Occurrence and distribution of aromatic L-amino acid (L-DOPA) decarboxylase in the human brain. J Neurochem 19:1549-1559.
34. Nagatsu T (1991) Genes for human catecholamine-synthesizing enzymes. Neurosci Res 12:315-345.
35. 11C]DOPA PET. Schizophr Res 108: 78-84.
36. 11C]DOPA to assess dopaminergic metabolism: effect of inhibitors of L-amino acid decarboxylase, monoamine oxidase, and catechol-O-methyltransferase on rat striatal dialysate. J Cereb Blood Flow Metab 31:124-131.
37. Oldendorf WH (1971) Brain uptake of radiolabeled amino acids, amines, and hexoses after arterial injection. Am J Physiol 221:1629-1639.
38. Pardridge WM (1977) Kinetics of competitive inhibition of neutral amino acid transport across the blood-brain barrier. J Neurochem 28:103-108.
39. Patlak CS, Blasberg RG (1985) Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations. J Cereb Blood Flow Metab 5:584-590.
40. 2) receptor availability predicts socially desirable responding. Neuroimage 34:1782-1789.
41. +-dependent uptake of the neurotransmitter candidate L-DOPA in the CNS. Neuroscience 104:1-14.
42. 11C]-L-3,4-dihydroxyphenylalanine (DOPA) in the primate by positron emission tomography. Acta Neurol Scand 85:166-173.
43. Watson CC, Newport D, Casey ME (1996) A single scatter simulation technique for scatter correction in 3D PET. In: Three-dimensional image reconstruction in radiology and nuclear medicine (Grangeat P, Amans JL, eds), pp 255-268. Dordrecht, The Netherlands: Kluwer Academic.